Wegovy is a prescription injectable medication indicated for chronic weight management in adults and pediatric patients aged 12 and older. It contains the active ingredient semaglutide, which belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists.
Wegovy works by mimicking a naturally occurring hormone that targets areas of the brain involved in regulating appetite and food intake. This helps individuals feel fuller faster, slows down the emptying of the stomach, and reduces overall calorie consumption. It is designed to be used as an adjunct to a reduced-calorie diet and increased physical activity.
Clinical Overview & Profile
Active Ingredient:Semaglutide (available in pre-filled, single-dose injection pens).
Therapeutic Class: GLP-1 receptor agonist.
Administration Route:Subcutaneous injection administered once weekly on the same day each week, at any time of day, with or without meals. The typical injection sites are the abdomen, thigh, or upper arm.
Dosing Schedule: Treatment follows a strict escalation schedule to minimize gastrointestinal side effects. It begins at a low dose (0.25 mg weekly) and is gradually increased every 4 weeks through 0.5 mg, 1.0 mg, and 1.7 mg, up to the full maintenance dose of 2.4 mg weekly.
Common Side Effects: Nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, and dyspepsia (indigestion).
Talk to your pharmacist or doctor before taking Wegovy if you:
Have an inflamed pancreas.
Have diabetes.
Have low blood sugar (Hypoglycemia).
Have diabetes-related eye diseases.
Size
0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg
Reviews
There are no reviews yet.
Be the first to review “Wegovy Injections”Cancel Reply
Reviews
There are no reviews yet.